Dr Jonathan Cohen
Honorary (Senior Fellow)
Department of Paediatrics
80 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Phase 2, open-label INSPIRE trial to assess the tolerability and effectiveness of transdermal cannabidiol gel in children and adolescents with 22q11.2 deletion syndrome (ZYN2-CL-031)
DOI: 10.1186/s11689-026-09687-z2025
Journal article
Long-term safety and tolerability of transdermal cannabidiol gel in children and adolescents with Fragile X syndrome (ZYN2-CL-017): an interim analysis of an ongoing open-label extension study
DOI: 10.1186/s11689-025-09657-x2025
Journal article
The immunocompromised traveller
2025
Journal article
The pregnant traveller
2025
Journal article
Correspondence on “No association between FMR1 premutation and either ADHD or anxiety in 53,707 women undergoing genetic testing for family planning purposes” by Klausner et al
DOI: 10.1016/j.gim.2025.1015112025
Journal article
The older traveller
2023
Journal article
Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation
DOI: 10.3390/cells12182330
RECENT SCHOLARLY WORKS
2023
Journal article
Social and physical predictors of mental health impact in adult women who have an FMR1 premutation
DOI: 10.1016/j.gimo.2023.1008292022
Journal article
A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)
DOI: 10.1186/s11689-022-09466-62022
Journal article
The International Fragile X Premutation Registry: building a resource for research and clinical trial readiness
DOI: 10.1136/jmedgenet-2022-108568